Book contents
- The Cambridge Handbook of the Imagination
- The Cambridge Handbook of the Imagination
- Copyright page
- Dedication
- Contents
- Figures
- Contributors
- Acknowledgments
- 1 Surveying the Imagination Landscape
- Part I Theoretical Perspectives on the Imagination
- Part II Imagery-Based Forms of the Imagination
- Part III Intentionality-Based Forms of the Imagination
- Part IV Novel Combinatorial Forms of the Imagination
- Part V Phenomenology-Based Forms of the Imagination
- Part VI Altered States of the Imagination
- 40 Dreaming: Beyond Imagination and Perception
- 41 Dreaming is Imagination Roaming Freely, Based On Embodied Simulation, and Subserved by an Unconstrained Default Network
- 42 Aphantasia
- 43 Hypnosis and Imagination
- 44 Hallucinations and Imagination
- 45 The Psychiatry of Imagination
- 46 Meditation and Imagination
- 47 Flow in Performance and Creative Cognition – An Optimal State of Task-Based Adaptation
- 48 The Force of the Imagination
- Name Index
- Subject Index
- References
44 - Hallucinations and Imagination
from Part VI - Altered States of the Imagination
Published online by Cambridge University Press: 26 May 2020
Edited by
Book contents
- The Cambridge Handbook of the Imagination
- The Cambridge Handbook of the Imagination
- Copyright page
- Dedication
- Contents
- Figures
- Contributors
- Acknowledgments
- 1 Surveying the Imagination Landscape
- Part I Theoretical Perspectives on the Imagination
- Part II Imagery-Based Forms of the Imagination
- Part III Intentionality-Based Forms of the Imagination
- Part IV Novel Combinatorial Forms of the Imagination
- Part V Phenomenology-Based Forms of the Imagination
- Part VI Altered States of the Imagination
- 40 Dreaming: Beyond Imagination and Perception
- 41 Dreaming is Imagination Roaming Freely, Based On Embodied Simulation, and Subserved by an Unconstrained Default Network
- 42 Aphantasia
- 43 Hypnosis and Imagination
- 44 Hallucinations and Imagination
- 45 The Psychiatry of Imagination
- 46 Meditation and Imagination
- 47 Flow in Performance and Creative Cognition – An Optimal State of Task-Based Adaptation
- 48 The Force of the Imagination
- Name Index
- Subject Index
- References
Summary
There is a strong overlap between imagined and hallucinatory phenomena in the sense that both are internal representations of external things that are not present at the time. Relationships between hallucinations and wider aspects of imagination are complex and individual, with a lack of systematic evidence. There appears to be a close relationship between the brain areas responsible for veridical, imagined, and hallucinatory perception, though more data is needed. However, how activity varies within and outside these areas in order to create different types of imagination is not at all clear. Drug effects provide one avenue for systematically exploring links between hallucinations and imagination. Drugs that cause hallucinations also tend to affect wider imagination and creativity, though results are variable and are open to alternative explanations. Nevertheless, these effects suggest that wider, non-perceptual, brain systems are involved in the generation of imaginative responses to hallucinations. Future investigations need to define imagination more closely, have tighter designs, and combine approaches.
- Type
- Chapter
- Information
- The Cambridge Handbook of the Imagination , pp. 728 - 759Publisher: Cambridge University PressPrint publication year: 2020
References
Abraham, A. D., Fontaine, H. M., Song, A. J., et al. (2018). κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioural Inhibition. Neuropsychopharmacology, 43(2), 362–372.Google Scholar
Addy, P. H., Garcia-Romeu, A., Metzger, M., and Wade, J. (2015). The Subjective Experience of Acute, Experimentally-Induced Salvia Divinorum Inebriation. Journal of Psychopharmacology, 29(4), 426–435.Google Scholar
Akers, B. P., Ruiz, J. F., Piper, A., and Ruck, C. A. P. (2011) A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms? Economic Botany, 65(2), 121–128.Google Scholar
Aleman, A., and Larøi, F. (2008). Hallucinations: The Science of Idiosyncratic Perception. Washington, DC: American Psychological Association.CrossRefGoogle Scholar
de Araujo, B., Ribeiro, S., Cecchi, G. A., et al. (2012) Seeing with the Eyes Shut: Neural Basis of Enhanced Imagery Following Ayahuasca Ingestion. Human Brain Mapping, 33(11), 2550–2560.Google Scholar
Bachner-Melman, R., Dina, C., Zohar, A. H., et al. (2005). AVPR1a and SLC6A4 Gene Polymorphisms Are Associated with Creative Dance Performance. PLoS Genetics, 1(3), e42.Google Scholar
Bliem, B., Unterrainer, H. F., Papousek, I., Weiss, E. M., and Fink, A. (2013). Creativity in Cannabis-Users and in Drug Addicts in Maintenance Treatment and in Rehabilitation. Neuropsychiatry, 27(1), 2–10.Google Scholar
Block, R. I., and Wittenborn, J. R. (1984). Marijuana Effects on Visual Imagery in a Paired-Associate Task. Perceptual and Motor Skills, 58(3), 759–766.Google Scholar
Blom, J. D. (2015). Defining and Measuring Hallucinations and their Consequences – What Is Really the Difference between a Veridical Perception and a Hallucination? Categories of Hallucinatory Experiences. In Collerton, D, Mosimann, U, and Perry, E (eds.), The Neuroscience of Visual Hallucinations. West Sussex, UK: John Wiley & Sons, 23–45.Google Scholar
Boot, N., Baas, M., van Gaal, S., et al. (2017). Creative Cognition and Dopaminergic Modulation of Fronto-Striatal Networks: Integrative Review and Research Agenda. Neuroscience & Biobehavioural Reviews, 78, 13–23.CrossRefGoogle ScholarPubMed
Canesi, M., Rusconi, M. L., Moroni, F., et al. (2016). Creative Thinking, Professional Artists, and Parkinson’s Disease. Journal of Parkinson’s Disease, 6(1), 239–246.Google Scholar
Caruncho, M. V., and Fernández, F. B. (2011). The Hallucinations of Frédéric Chopin. Medical Humanities, 37(1), 5–8.Google Scholar
Collerton, D., Mosimann, U. P., and Perry, E. K. (eds.) (2015). The Neuroscience of Visual Hallucinations. West Sussex, UK; Hoboke, NJ: John Wiley & Sons.Google Scholar
Collerton, D., Perry, E., and McKeith, I. (2005). Why People See Things That Are Not There: A Novel Perception and Attention Deficit Model for Recurrent Complex Visual Hallucinations. Behavioral and Brain Sciences, 28(6), 737–757.Google Scholar
Collerton, D., Taylor, J. P., Tsuda, I., et al. (2016). How Can We See Things That Are Not There? Current Insights into Complex Visual Hallucinations. Journal of Consciousness Studies, 23(7–8), 195–227.Google Scholar
Cruz, A., Domingos, S., Gallardo, E., and Martinho, A. (2017). A Unique Natural Selective Kappa-Opioid Receptor Agonist, Salvinorin A, and Its Roles in Human Therapeutics. Phytochemistry, 137, 9–14.Google Scholar
Davis, R. E., Callahan, M. J., Dickerson, M., and Downs, D. A. (1992). Pharmacologic Activity of CI-977, a Selective Kappa Opioid Agonist, in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics, 261(3), 1044–1049.Google ScholarPubMed
De Dreu, C. K., Baas, M., and Boot, N. C. (2015). Oxytocin Enables Novelty Seeking and Creative Performance through Upregulated Approach: Evidence and Avenues for Future Research. Wiley Interdisciplinary Reviews: Cognitive Science, 6(5), 409–417.Google Scholar
De Quincy, T. (1821) Confessions of an English Opium-Eater. London Magazine, IV(xxii), 353–379.Google Scholar
Dittrich, A., Bickel, P., Schöpf, J., and Zimmer, D. (1976). Comparison of Altered States of Consciousness Induced by the Hallucinogens (–)-Delta9-Trans- Tetrahydrocannabinol (Delta9-THC) and N,N-Dimethyltryptamine (DMT). Archiv für Psychiatrie und Nervenkrankheiten, 223(1), 77–87.Google Scholar
Dos Santos, R. G., Osório, F. L., Crippa, J. A. S., and Hallak, J. E. C. (2016). Classical Hallucinogens and Neuroimaging: A Systematic Review of Human Studies: Hallucinogens and Neuroimaging. Neuroscience & Biobehavioural Reviews, 71, 715–728.CrossRefGoogle ScholarPubMed
Dudley, R., Wood, M., Spencer, H., et al. (2012). Identifying Specific Interpretations and Use of Safety Behaviours in People with Distressing Visual Hallucinations: An Exploratory Study. Behavioural and Cognitive Psychotherapy, 40(3), 367–375.Google Scholar
Ellis, H. (1898). Mescal: A New Artificial Paradise. The Contemporary Review, 73, 130–141.Google Scholar
Faust-Socher, A., Kenett, Y. N., Cohen, O. S., Hassin-Baer, S., and Inzelberg, R. (2014). Enhanced Creative Thinking under Dopaminergic Therapy in Parkinson Disease. Annals of Neurology, 75(6), 935–942.Google Scholar
Ffytche, D. H., Howard, R. J., Brammer, M. J., et al. (1998). The Anatomy of Conscious Vision: An fMRI Study of Hallucinations. Nature Neuroscience, 1(8), 738–742.Google Scholar
Finegersh, A., Rompala, G. R., Martin, D. I., and Homanics, G. E. (2015). Drinking beyond a Lifetime: New and Emerging Insights into Paternal Alcohol Exposure on Subsequent Generations. Alcohol, 49(5), 461–470.Google Scholar
Finkelstein, H. (1975). Dali’s Paranoia-Criticism or the Exercise of Freedom. Twentieth Century Literature, 21(1), 59–71.Google Scholar
Freeman, D. (2007). Suspicious Minds: The Psychology of Persecutory Delusions. Clinical Psychology Review, 27(4), 425–457.Google Scholar
Frucht, S. J., and Bernsohn, L. (2002). Visual Hallucinations in PD. Neurology, 59(12), 1965.Google Scholar
Gallimore, A. R. (2015). Restructuring Consciousness – The Psychedelic State in Light of Integrated Information Theory. Frontiers in Human Neuroscience, 9, 346.Google Scholar
Gallimore, A. R., and Strassman, R. J. (2016). A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience. Frontiers in Pharmacology, 7, 211.Google Scholar
Gauther, T. (1846) Le Club des Haschischins. Revue des Deux Mondes, période initiale, 13(1846), 520–535.Google Scholar
Goetz, C. G., Vaughan, C. L., Goldman, J. G., and Stebbins, G. T. (2014). I Finally See What You See: Parkinson’s Disease Visual Hallucinations Captured with Functional Neuroimaging. Movement Disorders, 29(1), 115–117.Google Scholar
Holm-Hadulla, R. M., and Bertolino, A. (2014). Creativity, Alcohol and Drug Abuse: The Pop Icon Jim Morrison. Psychopathology, 47(3), 167–173.Google Scholar
Holroyd, S., Currie, L., Wooten, G. F. (2001). Prospective Study of Hallucinations and Delusions in Parkinson’s Disease. Journal of Neurology, Neurosurgery & Psychiatry, 70, 734–738.CrossRefGoogle ScholarPubMed
Howe, J. (2001). Edvard Munch: Psyche, Symbol and Expression. Boston, MA: Boston College, McMullen Museum of Art.Google Scholar
Inzelberg, R. (2013). The Awakening of Artistic Creativity and Parkinson’s Disease. Behavioral Neuroscience, 127(2), 256–261.Google Scholar
Iwaki, H., and Nomoto, M. (2014). The Adverse Effects of Anticholinergic Drugs. Brain and Nerve, 66(5), 551–560.Google Scholar
Janiker, O., and Dobkin de Rios, M. (1989). LSD and Creativity. Journal of Psychoactive Drugs, 21(1), 129–134.Google Scholar
Kaelen, M., Roseman, L., Kahan, J., et al. (2016). LSD Modulates Music-Induced Imagery via Changes in Parahippocampal Connectivity. European Neuropsychopharmacology, 26(7), 1099–1109.Google Scholar
Kennaway, J. (2017). “Those Unheard Are Sweeter.” Musical Hallucinations in Nineteenth-Century Medicine and Culture. Terrain: Anthropologie & Sciences Humaines, 68, doi : 10.4000/terrain.16426.Google Scholar
Kenney, S. (1975). Two Endings: Virginia Woolf’s Suicide and Between the Acts. University of Toronto Quarterly, 44(4), 265–289.CrossRefGoogle Scholar
Klusonová, H., Vlková, J., and Visnovský, P. (2005). Natural Opium as One of the Possibilities for Drug Abusers. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 149(2), 481–483.Google Scholar
Kometer, M., Schmidt, A., Jäncke, L., and Vollenweider, F. X. (2013). Activation of Serotonin 2 A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations. Journal of Neuroscience, 33(25), 10544–10551.Google Scholar
Koukkou, M., and Lehmann, D. (1976). Human EEG Spectra before and during Cannabis Hallucinations. Biological Psychiatry, 11(6), 663–677.Google Scholar
Kowal, M. A., Hazekamp, A., Colzato, L. S., et al. (2015). Cannabis and Creativity: Highly Potent Cannabis Impairs Divergent Thinking in Regular Cannabis Users. Psychopharmacology, 232(6), 1123–1134.Google Scholar
Kuypers, K. P., Riba, J., de la Fuente Revenga, M., et al. (2016). Ayahuasca Enhances Creative Divergent Thinking while Decreasing Conventional Convergent Thinking. Psychopharmacology, 233(18), 3395–3403.Google Scholar
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., and Kalueff, A. V. (2017). Psychedelic Drugs in Biomedicine. Trends in Pharmacological Sciences, 38(11), 992–1005.Google Scholar
LaFrance, E. M., and Cuttler, C. (2017). Inspired by Mary Jane? Mechanisms underlying Enhanced Creativity in Cannabis Users. Consciousness and Cognition, 56, 68–76.Google Scholar
Landon, M., and Fischer, R. (1970). On Similar Linguistic Structures in Creative Performance and Psilocybin-Induced Experience. Confinia Psychiatrica, 13(2), 115–138.Google ScholarPubMed
Leichti, M. E. (2017). Modern Clinical Research on LSD. Neuropsychopharmacology, 42(11), 2114–2127.Google Scholar
Leikin, J. B., Krantz, A. J., Zell-Kanter, M., Barkin, R. L., and Hryhorczuk, D. O. (1989). Clinical Features and Management of Intoxication due to Hallucinogenic Drugs. Medical Toxicology and Adverse Drug Experience, 4(5), 324–350.Google Scholar
Lhommée, E., Batir, A., Quesada, J. L., et al. (2014). Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease. Frontiers in Neurology, 5, 55.Google Scholar
Liu, J., Li, J., Feng, L., et al. (2014). Seeing Jesus in Toast: Neural and Behavioral Correlates of Face Pareidolia. Cortex, 53, 60–77.Google Scholar
Maqueda, A. E., Valle, M., Addy, P. H., et al. (2015). Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans. International Journal of Neuropsychopharmacology, 18(12), pyv065.Google Scholar
Martin, D. A., and Nichols, C. D. (2017). The Effects of Hallucinogens on Gene Expression. Current Topics in Behavioural Neurosciences, 36, 1–22.Google Scholar
McKenna, T. (1999). Food of the Gods: The Search for the Original Tree of Knowledge. A Radical History of Plants, Drugs and Human Evolution. London, UK: Random House.Google Scholar
McNorgan, C. (2012). A Meta-Analytic Review of Multisensory Imagery Identifies the Neural Correlates of Modality-Specific and Modality-General Imagery. Frontiers in Human Neuroscience, 6, 285.Google Scholar
Minor, K. S., Firmin, R. L., Bonfils, K. A., et al. (2014). Predicting Creativity: The Role of Psychometric Schizotypy and Cannabis Use in Divergent Thinking. Psychiatry Research, 220(1–2), 205–210.Google Scholar
Naselaris, T., Olman, C. A., Stansbury, D. E., Ugurbil, K., and Gallant, J. L. (2015). A Voxel-Wise Encoding Model for Early Visual Areas Decodes Mental Images of Remembered Scenes. Neuroimage, 105, 215–228.Google Scholar
Nielsen, T. A. (1992). A Self-Observational Study of Spontaneous Hypnagogic Imagery Using the Upright Napping Procedure. Imagination, Cognition and Personality, 11(4), 353–366.Google Scholar
Novak, S. J. (1997). LSD Before Leary. Sidney Cohen’s Critique of 1950s Psychedelic Drug Research. Isis: An International Review Devoted to the History of Science and Its Cultural Influences, 88(1), 87–110.Google Scholar
O’Craven, K. M., and Kanwisher, N. (2000). Mental Imagery of Faces and Places Activates Corresponding Stimulus-Specific Brain Regions. Journal of Cognitive Neuroscience, 126, 1013–1023.Google Scholar
Orsolini, L., Papanti, G. D., de Berardis, D., et al. (2017). The “Endless Trip” Among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review. Frontiers in Psychiatry, 8, 240.Google Scholar
Osborne, A. L., Solowij, N., and Weston-Green, K. (2017). A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia. Neuroscience and Biobehavioural Reviews, 72, 310–324.Google Scholar
Ostwald, P. F. (1987). Schumann: The Inner Voices of a Musical Genius. Boston, MA: Northeastern University Press.Google Scholar
Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., et al. (2015). The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network. PLoS One, 10(2), e0118143.Google Scholar
Perry, E. K., and Perry, R. H. (1995). Acetylcholine and Hallucinations: Disease-Related Compared to Drug-Induced Alterations in Human Consciousness. Brain and Cognition, 28(3), 240–258.Google Scholar
Prado, V. F., Janickova, H., Al-Onaizi, M. A., and Prado, M. A. (2017). Cholinergic Circuits in Cognitive Flexibility. Neuroscience, 345, 130–141.Google Scholar
Riley, S. C., and Blackman, G. (2008). Between Prohibitions: Patterns and Meanings of Magic Mushroom Use in the UK. Substance Use and Misuse, 43(1), 55–71.Google Scholar
Rothenberg, A. (2001). Bipolar Illness, Creativity, and Treatment. Psychiatric Quarterly, 72(2), 131–147.Google Scholar
Sessa, B. (2008). Is It Time to Revisit the Role of Psychedelic Drugs in Enhancing Human Creativity? Psychopharmacology, 22(8), 821–827.Google Scholar
Shine, J. M., Keogh, R., O’Callaghan, C., et al. (2015). Imagine That: Elevated Sensory Strength of Mental Imagery in Individuals with Parkinson’s Disease and Visual Hallucinations. Proceedings of the Royal Society of London B: Biological Sciences, 282(1798), 2014–2047.Google Scholar
Sireteanu, R., Oertel, V., Mohr, H., Linden, D., and Singer, W. (2008). Graphical Illustration and Functional Neuroimaging of Visual Hallucinations during Prolonged Blindfolding: A Comparison to Visual Imagery. Perception, 37, 1805–1821.Google Scholar
Slotnick, S.D., Thompson., W.L., and Kosslyn, M. (2005). Visual Mental Imagery Induces Retinotopically Organised Activation of Early Visual Areas. Cerebral Cortex, 15, 1570–1583.Google Scholar
Sweat, N. W., Bates, L. W., and Hendricks, P. S. (2016). The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving. Journal of Psychoactive Drugs, 48(5), 344–350.Google Scholar
Takahashi, K., and Watanabe, K. (2013). Gaze Cueing by Pareidolia Faces. i-Perception, 4, 490–492.CrossRefGoogle ScholarPubMed
Tan, M., and Gan, T. J. (2016). Opioid-Induced Hallucination: Distressful or Sought After? Anaesthesia and Analgesia, 123(4), 818–819.Google Scholar
Teaktong, T., Piggott, M. A., Mckeith, I. G., et al. (2005). Muscarinic M2 and M4 Receptors in Anterior Cingulate Cortex: Relation to Neuropsychiatric Symptoms in Dementia with Lewy Bodies. Behavioural Brain Research, 161(2), 299–305.Google Scholar
ten Berge, J. (2002). Jekyll and Hyde Revisited: Paradoxes in the Appreciation of Drug Experiences and Their Effects on Creativity. Journal of Psychoactive Drugs, 34(3), 249–262.Google Scholar
Thirion, B., Duchesnay, E., Hubbard, E., et al. (2006). Inverse Retinotopy: Inferring the Visual Content of Images from Brain Activation Patterns. Neuroimage, 33, 1104–1116.Google Scholar
Thomson, C., Wilson, R., Collerton, D., Freeston, M., and Dudley, R. (2017). Cognitive Behavioural Therapy for Visual Hallucinations: An Investigation using a Single-Case Experimental Design. The Cognitive Behaviour Therapist, 10.Google Scholar
Uchiyama, M., Nishio, Y., Yokoi, K., et al. (2012). Pareidolias: Complex Visual Illusions in Dementia with Lewy Bodies. Brain, 135, 2458–2469.Google Scholar
Uchiyama, M., Nishio, Y., Yokoi, K.(2015). Pareidolia in Parkinson’s Disease without Dementia: A Positron Emission Tomography Study. Parkinsonism and Related Disorders, 21, 603–609.Google Scholar
van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P., and Krabbendam, L. (2009). A Systematic Review and Meta-Analysis of the Psychosis Continuum: Evidence for a Psychosis Proneness–Persistence–Impairment Model of Psychotic Disorder. Psychological Medicine, 39(2), 179–195.Google Scholar
Varrone, A., Svenningsson, P., Marklund, P., et al. (2015). 5-HT1B Receptor Imaging and Cognition: A Positron Emission Tomography Study in Control Subjects and Parkinson’s Disease Patients. Synapse, 69(7), 365–374.Google Scholar
Vickers, N. (2015). Opium as a Literary Stimulant: The Case of Samuel Taylor Coleridge. International Review Neurobiology, 120, 327–338.Google Scholar
Volf, N. V., Kulikov, A. V., Bortsov, C. U., and Popova, N. K. (2009). Association of Verbal and Figural Creative Achievement with Polymorphism in the Human Serotonin Transporter Gene. Neuroscience Letters, 463(2), 154–157.Google Scholar
Vollenweider, F. X., Vontobel, P., Hell, D., and Leenders, K. L. (1999). 5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man – a PET study with [11 C]raclopride. Neuropsychopharmacology, 20(5), 424–433.Google Scholar
Waters, F., Collerton, D., Ffytche, D. H., et al. (2014). Visual Hallucinations in the Psychosis Spectrum and Comparative Information from Neurodegenerative Disorders and Eye Disease. Schizophrenia Bulletin, 40(suppl 4), S233–S245.Google Scholar
Webster, R., and Holroyd, S. (2000). Prevalence of Psychotic Symptoms in Delirium. Psychosomatics, 41(6), 519–522.Google Scholar
Wiebe, T. H., Sigurdson, E. S., and Katz, L. Y. (2006). Angel’s Trumpet (Datura stramonium) Poisoning and Delirium in Adolescents in Winnipeg, Manitoba: Summer 2006. Paediatrics and Child Health, 13(3), 193–196.Google Scholar
Wood, L. D. (2010). Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinson’s Disease. Drugs & Aging, 27(4), 295–310.Google Scholar
Yokoi, K., Nishio, Y., Uchiyama, M., et al. (2014). Hallucinators Find Meaning in Noises: Pareidolic Illusions in Dementia with Lewy Bodies. Neuropsychologia, 56(1), 245–254.Google Scholar
- 1
- Cited by